Currently out of the existing stock ratings of Anthony Petrone, 156 are a BUY (80.41%), 35 are a HOLD (18.04%), 3 are a SELL (1.55%).

Anthony Petrone

Work Performance Price Targets & Ratings Chart

Analyst Anthony Petrone works at MIZUHO with a stock forecast success ratio of 49.46% fulfilled within 174.57 days on average. Previously, Anthony Petrone worked at JEFFERIES.

Anthony Petrone’s has documented 401 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ESTA, Establishment Labs Holdings at 01-Apr-2024.

Wall Street Analyst Anthony Petrone

Analyst best performing recommendations are on VRAY (VIEWRAY).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 1/24/2023. The price target of $245 was fulfilled within 1 day with a profit of $12.98 (5.03%) receiving and performance score of 50.31.

Average potential price target upside

of $69.04 (43.46%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $33.73 (30.46%) on ZBH (ZIMMER BIOMET HOLDINGS).
of $23.59 (11.71%) on TFX (TELEFLEX ORPORATED).

ATRS Antares Pharma COO The Cooper Companies . Common Stock EW Edwards Lifesciences Corp HAE Haemonetics MNK Mallinckrodt plc RMD ResMed TARS Tarsus Pharmaceuticals VAR Varian Medical Systems VREX Varex Imaging Corp ALC Alcon AG GKOS Glaukos Corp HOLX Hologic LMAT LeMaitre Vascular LNTH Lantheus Holdings ZBH Zimmer Biomet Holdings LIVN LivaNova PLC ABMD ABIOMED ABT Abbott Laboratories ADMA ADMA Biologics ESTA Establishment Labs Holdings MDT Medtronic PLC STAA STAAR Surgical Company ISRG Intuitive Surgical INSP Inspire Medical Systems NVRO Nevro Corp TFX Teleflex orporated VRAY ViewRay MDXG MiMedx Group AXNX Axonics Modulation Technologies BSX Boston Scientific Corp

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Elliot Wilbur (RAYMOND JAMES)